✦ LIBER ✦

Regulation of antiviral drugs and vaccines in the United States

✍ Scribed by Nancy L. Buc

Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 371 KB
Volume: 4
Category: Article
ISSN: 0958-1669
DOI: 10.1016/0958-1669(93)90093-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of transportation noise in th

Regulation of transportation noise in the United States

✍ E. Cuadra; W.C. Sperry; W.E. Roper 📂 Article 📅 1975 🏛 Elsevier Science 🌐 English ⚖ 1009 KB

Guidelines for Good Epidemiology Practic

Guidelines for Good Epidemiology Practices for Drug, Device, and Vaccine Research in the United States

📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 1 views

95/04744 Fundamentals of nuclear regulat

95/04744 Fundamentals of nuclear regulation in the United States

📂 Article 📅 1995 🏛 Elsevier Science ⚖ 185 KB

Public health impact of antiviral therap

Public health impact of antiviral therapy for hepatitis C in the United States

✍ Michael L. Volk; Rachel Tocco; Sameer Saini; Anna S.F. Lok 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB 👁 1 views

Despite dramatic improvements in antiviral therapy for hepatitis C, there is reason to believe that the uptake of antiviral therapy remains limited. The aims of this study were to determine the number of patients being treated with antiviral therapy in the U.S., to estimate the public health impact

Incentive regulation and the change in p

Incentive regulation and the change in productive efficiency in telecommunications in the United States

✍ Noel D. Uri 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Efficacy of hepatitis B vaccine against

Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model

✍ Saleem Kamili; Vitini Sozzi; Geoff Thompson; Katie Campbell; Christopher M. Walk 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

Hepatitis B virus (HBV) mutants resistant to treatment with nucleoside or nucleotide analogs and those with the ability to escape from HBV-neutralizing antibody have the potential to infect HBV-vaccinated individuals. To address this potential serious public health challenge, we tested the efficacy